Nexentis appoints computational chemistry expert to MitoCareX advisory board
AI Summary- Nexentis appointed Prof. Dan T. Major to MitoCareX’s Scientific Advisory Board.
- MitoCareX is wholly owned by Nexentis Technologies, according to the announcement.
- MitoCareX previously began a drug-discovery collaboration with Boltz, an AI research lab.